PACS

PACS PACS Group, Inc.

Stock · NYSE · United States · Healthcare · US69380Q1076

NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by PACS Group, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price 49.60 USD -1.20%

52-week range 10.31 – 51.68

Dividend yield—

Market cap7.9B

NowoTrade score 65 Grade A

Price history

Daily prices in USD.

Updated 07 Nov 2026 10:28. Information, not advice.

Results

Next results 25 Feb 2027 in 110 days · 16:00 · estimate 0.63

Last results 0.63 vs 0.58 estimated 03 Nov 2026 · Beat +8.1%

Beat the estimate 6 of 7 1 missed · 0 in line · 4 beats in a row

Average surprise +11.7% reported against the estimate, last 7 quarters

Earnings per share: estimate and reported

Estimate Reported: beat Reported: miss In line

Quarterly results

Date	EPS estimate	EPS reported	Surprise	Result
25 Feb 2027 16:00	0.63	—	—	Upcoming
03 Nov 2026 16:00	0.58	0.63	+8.1%	Beat
04 Aug 2026 16:00	0.56	0.63	+11.7%	Beat
11 May 2026 16:00	0.41	0.64	+56.8%	Beat
26 Feb 2026 16:00	0.46	0.57	+25.7%	Beat
19 Nov 2025 16:00	0.33	0.09	-73.4%	Miss
12 Aug 2024 16:00	0.35	0.48	+36.6%	Beat
13 May 2024 18:00	0.29	0.34	+16.6%	Beat

Annual results · USD

Year	Revenue	Change	Net income	Net margin	EPS	EPS change	Free cash flow
2025	5.3B	+29.3%	191.5M	3.6%	1.22	+221.1%	155.1M
2024	4.1B	+31.4%	55.8M	1.4%	0.38	-50.3%	17.5M
2023	3.1B	+28.5%	112.9M	3.6%	0.76	-23.8%	-109.1M
2022	2.4B	—	150.5M	6.2%	1.00	—	14.4M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Day Week Month

Price history in USD, by day
Period	Opening price	High	Low	Closing price	Change	Volume
23 Jul 2026	44.32	45.18	43.94	44.82	-0.53%	568,000
22 Jul 2026	44.96	45.48	44.04	45.06	-1.10%	850,500
21 Jul 2026	44.58	46.15	44.28	45.56	+1.86%	864,000
20 Jul 2026	46.15	46.94	44.59	44.73	-3.03%	758,600
17 Jul 2026	45.24	47.17	44.20	46.13	+1.10%	710,300
16 Jul 2026	44.34	46.38	44.14	45.63	+1.40%	866,800
15 Jul 2026	45.10	45.84	43.59	45.00	+0.11%	1,310,200
14 Jul 2026	43.32	45.19	43.00	44.95	+3.88%	1,274,700
13 Jul 2026	43.00	44.10	42.53	43.27	+0.12%	630,800
10 Jul 2026	43.65	43.82	42.05	43.22	-1.37%	687,900
09 Jul 2026	44.47	45.36	43.71	43.82	-0.45%	499,000
08 Jul 2026	44.21	45.29	43.70	44.02	+0.92%	763,400
07 Jul 2026	44.90	45.31	43.28	43.62	-3.07%	904,900
06 Jul 2026	44.34	45.89	44.34	45.00	+1.17%	1,313,100
02 Jul 2026	44.35	45.20	43.92	44.48	+0.36%	1,080,200
01 Jul 2026	42.41	45.13	41.34	44.32	+3.94%	1,236,400
30 Jun 2026	41.63	43.93	39.82	42.64	+6.76%	1,451,000
29 Jun 2026	42.06	42.39	39.89	39.94	-4.66%	940,800
26 Jun 2026	40.01	41.97	40.01	41.89	+2.97%	1,918,700
25 Jun 2026	39.33	40.72	38.45	40.68	+4.71%	1,133,100
24 Jun 2026	37.54	39.10	37.37	38.85	+3.96%	1,234,900
23 Jun 2026	37.39	38.14	36.70	37.37	-1.06%	817,000
22 Jun 2026	37.01	37.86	36.75	37.77	+3.22%	899,100
18 Jun 2026	35.46	36.75	34.81	36.59	+3.83%	1,092,800
17 Jun 2026	35.50	36.46	34.67	35.24	-1.81%	610,700

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

PACS Group: Things Are Ramping Up, And The Discount Looks Attractive (opens in a new tab) SeekingAlpha · 06 Nov 2026 04:40
UBS Maintains Buy on PACS Group, Raises Price Target to $67 (opens in a new tab) Benzinga · 05 Nov 2026 20:36
Truist Securities Reiterates Buy on PACS Group, Raises Price Target to $65 (opens in a new tab) Benzinga · 05 Nov 2026 11:57
Stephens & Co. Maintains Overweight on PACS Group, Raises Price Target to $64 (opens in a new tab) Benzinga · 05 Nov 2026 10:50
PACS Group Inc (PACS) (Q3 2026) Earnings Call Highlights: Revenue Tops $1. ... (opens in a new tab) GuruFocus.com · 05 Nov 2026 03:11
PACS Group, Inc. (PACS) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 04 Nov 2026 20:04
PACS Group Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 04 Nov 2026 13:28
PACS Group, Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 04 Nov 2026 12:03
PACS Group Inc (NYSE:PACS) Raises Full-Year Guidance After Q3 Adjusted EPS Beat (opens in a new tab) ChartMill · 03 Nov 2026 23:55
PACS Group, Inc. (PACS) Q3 Earnings and Revenues Beat Estimates (opens in a new tab) Zacks · 03 Nov 2026 21:50
PACS Group, Inc. Reports Third Quarter 2026 Results (opens in a new tab) 03 Nov 2026 21:15
PACS Group Raises FY2026 Sales Guidance from $5.750B-$5.850B to $5.950B-$6.050B vs $5.851B Est (opens in a new tab) Benzinga · 03 Nov 2026 17:30
PACS Group, Inc. (PACS) Surges 6.2%: Is This an Indication of Further Gains? (opens in a new tab) Zacks · 16 Oct 2026 11:52
Lease Expansion Could Reshape The Case For PACS Group (PACS) Stock (opens in a new tab) Simply Wall St. · 16 Oct 2026 08:17
Is PACS Group (PACS) Cheap On Its Florida Nursing Home Expansion? (opens in a new tab) Simply Wall St. · 07 Oct 2026 17:13

Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close: 50.20 USD
Market cap: 7.9B
Exchange: NYSE
Country: United States
Sector: Healthcare
Industry: Medical Care Facilities
Currency: USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the score	Points	Why
Business growth Yearly growth of revenue and of earnings per share.	18.1 / 25	Revenue growth of 29.7% a year Earnings per share growth of 6.8% a year
Quality Return on equity, net margin and how stable the margins are.	16.8 / 25	ROE of 26%
Financial strength Net debt against operating earnings, interest cover and free cash flow.	13.3 / 20	Net debt is 6.7× EBITDA Free cash flow yield of 4.2%
Valuation Free cash flow yield and the P/E against its sector.	11.1 / 15	P/E 28.2 against 31.1 for its sector
Analysts How far the analysts' average target is from today's price.	9.7 / 10	Analysts' target is +19% from the price

Heavy debt: net debt is 6.7× EBITDA

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 6 points off.

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.

Figures

Valuation
Figure	Value	Reading	Sector median
P/E (trailing)	28.18×	Weak	31.09×
P/E (forward)	17.68×	Fair	14.98×
Price / book	6.48×	Weak	3.94×
Price / sales	1.38×	Good	3.37×
EV / EBITDA	22.52×	Weak	12.96×
Free cash flow yield	4.2%	Fair	2.6%

Quality
Figure	Value	Reading	Sector median
Gross margin	17.8%	Weak	59.2%
Operating margin	6.7%	Weak	7.4%
Net margin	4.9%	Weak	3.4%
Return on equity	26.5%	Good	5.7%
Return on assets	4.6%	Fair	3.6%

Growth
Figure	Value	Reading	Sector median
Revenue growth / year	29.7%	Good	10.8%
EPS growth / year	6.8%	Fair	10.2%

Financial health
Figure	Value	Reading	Sector median
Debt / equity	2.82×	Weak	0.46×
Net debt / EBITDA	6.69×	Weak	1.5×
Interest cover	10.92×	Good	3.26×
Current ratio	0.8×	Weak	2.35×

Dividends
Figure	Value	Reading	Sector median
Payout of earnings	0%	Weak	0%
Payout of free cash flow (3 years)	179.7%	Weak	—

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Follow PACS and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in